SCIENTURE HOLDINGS, INC.

SCNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Operating Activities
Net Income $289.0K $-2.8M $-1.1M $-2.0M $-2.1M
Depreciation & Amortization
Depreciation $13.0K $0 $3.8K $4.8K $4.0K
Amortization
Stock-Based Compensation $0 $576.4K
Net Cash from Operating Activities $171.7K $-503.5K $90.4K $-1.1M $-844.6K
Investing Activities
Capital Expenditures $11.0K
Business Acquisitions
Net Cash from Investing Activities $0 $-78.0K $11.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $-2.4K $1.4M $1.7M $936.5K
Net Change in Cash $169.2K $-64.0K $-617.1K $621.3K $80.9K
Free Cash Flow $-855.6K
← Newer Page 2 of 2 Older →